Literature DB >> 24427185

Ten ways to improve the treatment of depression and anxiety in adults.

Boadie W Dunlop1, Kelly Scheinberg2, Anne L Dunlop3.   

Abstract

Complaints of depression and anxiety are very common among adult patients seeking treatment in primary care settings, and primary care providers prescribe the majority of medications for these conditions. Psychiatrists are often asked to evaluate and manage patients with major depression or anxiety disorders who have not improved after treatment in primary care. We highlight ten frequently overlooked aspects of the care of patients who present with depression and anxiety in primary care. Chief among these aspects is the consideration of a thorough differential diagnosis, particularly bipolar disorder, psychotic disorders, dementia and substance abuse, each of which requires specific treatment approaches. Additional considerations include avoidance of medications or doses that may aggravate anxiety symptoms and regular follow-ups to assess symptomatic and functional improvement. Finally, it is important to actively manage the treatment through dose escalation, switching medications or employing additional treatment components until remission is achieved. Judicious use of benzodiazepine clonazepam and appropriate referrals to psychotherapy can contribute to optimal treatment outcomes.

Entities:  

Keywords:  antidepressive agents; anxiety disorders; depressive disorder; medical errors; primary healthcare

Year:  2013        PMID: 24427185      PMCID: PMC3822665     

Source DB:  PubMed          Journal:  Ment Health Fam Med        ISSN: 1756-834X


  42 in total

Review 1.  A systematic review of research findings on the efficacy of interpersonal therapy for depressive disorders.

Authors:  Marcelo Feijo de Mello; Jair de Jesus Mari; Josue Bacaltchuk; Helen Verdeli; Richard Neugebauer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-12       Impact factor: 5.270

Review 2.  Addiction: Part I. Benzodiazepines--side effects, abuse risk and alternatives.

Authors:  L P Longo; B Johnson
Journal:  Am Fam Physician       Date:  2000-04-01       Impact factor: 3.292

3.  A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders.

Authors:  Frances R Levin; John Mariani; Daniel J Brooks; Martina Pavlicova; Edward V Nunes; Vito Agosti; Adam Bisaga; Maria A Sullivan; Kenneth M Carpenter
Journal:  Addiction       Date:  2013-03-21       Impact factor: 6.526

Review 4.  Systematic review of multifaceted interventions to improve depression care.

Authors:  John W Williams; Martha Gerrity; Tracey Holsinger; Steve Dobscha; Bradley Gaynes; Allen Dietrich
Journal:  Gen Hosp Psychiatry       Date:  2007 Mar-Apr       Impact factor: 3.238

Review 5.  Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.

Authors:  Guy Chouinard
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

6.  Re-engineering systems for the treatment of depression in primary care: cluster randomised controlled trial.

Authors:  Allen J Dietrich; Thomas E Oxman; John W Williams; Herbert C Schulberg; Martha L Bruce; Pamela W Lee; Sheila Barry; Patrick J Raue; Jean J Lefever; Moonseong Heo; Kathryn Rost; Kurt Kroenke; Martha Gerrity; Paul A Nutting
Journal:  BMJ       Date:  2004-09-02

Review 7.  Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.

Authors:  J B Herman; A W Brotman; J F Rosenbaum
Journal:  J Clin Psychiatry       Date:  1987-10       Impact factor: 4.384

8.  Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review.

Authors:  Boadie W Dunlop; Paula G Davis
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

9.  Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey.

Authors:  C Cooper; P Bebbington; M King; T Brugha; H Meltzer; D Bhugra; R Jenkins
Journal:  Acta Psychiatr Scand       Date:  2007-07       Impact factor: 6.392

10.  Depression and somatization: a review. Part I.

Authors:  W Katon; A Kleinman; G Rosen
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

View more
  1 in total

Review 1.  The relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practice.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Hans-Peter Volz; Utako Birgit Barnikol; Erich Seifritz; Siegfried Kasper
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-03-22       Impact factor: 5.270

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.